Valion Bio VBIO
NASDAQ VBIO
$0.96 -0.16 (-14.63%)
At close: Oct 22, 2026 · 4:00 PM EDT

Valion Bio (VBIO) Capital Expenditures (2022 - 2025)

Updated

Valion Bio (VBIO) reported Capital Expenditures of $25,000 for Q4 2025, up 150.0% from the prior quarter.

Analysis

Valion Bio (VBIO) Capital Expenditures (2022 - 2025) Analysis & Trends

For FY2025, Valion Bio posted Capital Expenditures of $38,000.

  • Capital Expenditures has a three-year compound annual growth rate of 51.2% (FY2022 to FY2025).
  • By year, Capital Expenditures came in at $118,000 in FY2023 (+972.7%) and $11,000 in FY2022.
  • The Q4 2025 figure ranks as the highest quarterly Capital Expenditures since Q1 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 2.93 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 1.36 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 322.00 Mn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 893.00 Mn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 321.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 1.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 513.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 140.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 533.00 Mn
10 Valion Bio 130,630.24 -19.31 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 25,000.00
Sep 30, 2025 10,000.00
Jun 30, 2023 24,000.00
Mar 31, 2023 94,000.00
Sep 30, 2022 5,000.00
Mar 31, 2022 6,000.00
API Access

Valion Bio Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=VBIO&period=max&api_key=YOUR_API_KEY